Barclays Issues Pessimistic Forecast for Sotera Health (NASDAQ:SHC) Stock Price

Sotera Health (NASDAQ:SHC - Free Report) had its price objective trimmed by Barclays from $17.00 to $16.00 in a report released on Friday morning,Benzinga reports. The firm currently has an overweight rating on the stock.

SHC has been the subject of a number of other research reports. The Goldman Sachs Group initiated coverage on shares of Sotera Health in a research report on Friday, December 6th. They issued a "neutral" rating and a $14.00 price objective for the company. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $17.00 price target on shares of Sotera Health in a report on Thursday, November 21st. Finally, Citigroup increased their price target on Sotera Health from $18.00 to $20.00 and gave the stock a "buy" rating in a research report on Wednesday, November 6th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, Sotera Health currently has an average rating of "Moderate Buy" and a consensus target price of $15.92.

Sotera Health Stock Performance

Shares of SHC traded down $0.79 during trading hours on Friday, hitting $11.68. The stock had a trading volume of 2,427,078 shares, compared to its average volume of 1,015,204. The firm has a 50-day moving average price of $13.45 and a 200 day moving average price of $14.50. Sotera Health has a fifty-two week low of $10.71 and a fifty-two week high of $17.08. The firm has a market capitalization of $3.31 billion, a price-to-earnings ratio of 46.72 and a beta of 1.91. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88.

Institutional Investors Weigh In On Sotera Health

Several large investors have recently bought and sold shares of SHC. Louisiana State Employees Retirement System lifted its position in shares of Sotera Health by 20.5% in the third quarter. Louisiana State Employees Retirement System now owns 42,400 shares of the company's stock valued at $708,000 after acquiring an additional 7,200 shares in the last quarter. Wealth Enhancement Advisory Services LLC acquired a new position in Sotera Health in the 3rd quarter valued at $850,000. State of Alaska Department of Revenue lifted its holdings in Sotera Health by 31.7% in the 3rd quarter. State of Alaska Department of Revenue now owns 17,760 shares of the company's stock valued at $296,000 after purchasing an additional 4,270 shares in the last quarter. Pallas Capital Advisors LLC acquired a new stake in Sotera Health during the 3rd quarter worth $334,000. Finally, New York State Teachers Retirement System grew its holdings in shares of Sotera Health by 3.5% during the third quarter. New York State Teachers Retirement System now owns 53,500 shares of the company's stock worth $893,000 after buying an additional 1,800 shares in the last quarter. 91.03% of the stock is currently owned by hedge funds and other institutional investors.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.